Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Testosterone tridecanoate by Lipocine for Hepatic Encephalopathy: Likelihood of Approval
Testosterone tridecanoate is under clinical development by Lipocine and currently in Phase II for Hepatic Encephalopathy. According to GlobalData, Phase...
Testosterone tridecanoate by Lipocine for Sarcopenia: Likelihood of Approval
Testosterone tridecanoate is under clinical development by Lipocine and currently in Phase II for Sarcopenia. According to GlobalData, Phase II...
Testosterone tridecanoate by Lipocine for Decompensated Cirrhosis: Likelihood of Approval
Testosterone tridecanoate is under clinical development by Lipocine and currently in Phase II for Decompensated Cirrhosis. According to GlobalData, Phase...